Cargando…

Reduction of agalsidase beta infusion time in patients with fabry disease: A case series report and suggested protocol

Detalles Bibliográficos
Autores principales: Sánchez-Purificación, Aquilino, Castellano, Aránzazu, Gutiérrez, Belén, Gálvez, Marta, Díaz, Beatriz, Pérez, Tamara, Arnalich, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178677/
https://www.ncbi.nlm.nih.gov/pubmed/34136355
http://dx.doi.org/10.1016/j.ymgmr.2021.100755
_version_ 1783703622918340608
author Sánchez-Purificación, Aquilino
Castellano, Aránzazu
Gutiérrez, Belén
Gálvez, Marta
Díaz, Beatriz
Pérez, Tamara
Arnalich, Francisco
author_facet Sánchez-Purificación, Aquilino
Castellano, Aránzazu
Gutiérrez, Belén
Gálvez, Marta
Díaz, Beatriz
Pérez, Tamara
Arnalich, Francisco
author_sort Sánchez-Purificación, Aquilino
collection PubMed
description
format Online
Article
Text
id pubmed-8178677
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81786772021-06-15 Reduction of agalsidase beta infusion time in patients with fabry disease: A case series report and suggested protocol Sánchez-Purificación, Aquilino Castellano, Aránzazu Gutiérrez, Belén Gálvez, Marta Díaz, Beatriz Pérez, Tamara Arnalich, Francisco Mol Genet Metab Rep Correspondence Elsevier 2021-04-15 /pmc/articles/PMC8178677/ /pubmed/34136355 http://dx.doi.org/10.1016/j.ymgmr.2021.100755 Text en © 2021 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Correspondence
Sánchez-Purificación, Aquilino
Castellano, Aránzazu
Gutiérrez, Belén
Gálvez, Marta
Díaz, Beatriz
Pérez, Tamara
Arnalich, Francisco
Reduction of agalsidase beta infusion time in patients with fabry disease: A case series report and suggested protocol
title Reduction of agalsidase beta infusion time in patients with fabry disease: A case series report and suggested protocol
title_full Reduction of agalsidase beta infusion time in patients with fabry disease: A case series report and suggested protocol
title_fullStr Reduction of agalsidase beta infusion time in patients with fabry disease: A case series report and suggested protocol
title_full_unstemmed Reduction of agalsidase beta infusion time in patients with fabry disease: A case series report and suggested protocol
title_short Reduction of agalsidase beta infusion time in patients with fabry disease: A case series report and suggested protocol
title_sort reduction of agalsidase beta infusion time in patients with fabry disease: a case series report and suggested protocol
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178677/
https://www.ncbi.nlm.nih.gov/pubmed/34136355
http://dx.doi.org/10.1016/j.ymgmr.2021.100755
work_keys_str_mv AT sanchezpurificacionaquilino reductionofagalsidasebetainfusiontimeinpatientswithfabrydiseaseacaseseriesreportandsuggestedprotocol
AT castellanoaranzazu reductionofagalsidasebetainfusiontimeinpatientswithfabrydiseaseacaseseriesreportandsuggestedprotocol
AT gutierrezbelen reductionofagalsidasebetainfusiontimeinpatientswithfabrydiseaseacaseseriesreportandsuggestedprotocol
AT galvezmarta reductionofagalsidasebetainfusiontimeinpatientswithfabrydiseaseacaseseriesreportandsuggestedprotocol
AT diazbeatriz reductionofagalsidasebetainfusiontimeinpatientswithfabrydiseaseacaseseriesreportandsuggestedprotocol
AT pereztamara reductionofagalsidasebetainfusiontimeinpatientswithfabrydiseaseacaseseriesreportandsuggestedprotocol
AT arnalichfrancisco reductionofagalsidasebetainfusiontimeinpatientswithfabrydiseaseacaseseriesreportandsuggestedprotocol